vs
Side-by-side financial comparison of Ouster, Inc. (OUST) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $39.6M, roughly 1.6× SBC Medical Group Holdings Inc). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs -15.0%).
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
OUST vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.2M | $39.6M |
| Net Profit | — | $14.2M |
| Gross Margin | 60.2% | 73.1% |
| Operating Margin | 1.5% | 32.5% |
| Net Margin | — | 35.9% |
| Revenue YoY | 106.6% | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $0.10 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.2M | $39.6M | ||
| Q3 25 | $39.5M | $43.4M | ||
| Q2 25 | $35.0M | $43.4M | ||
| Q1 25 | $32.6M | $47.3M | ||
| Q4 24 | $30.1M | $44.4M | ||
| Q3 24 | $28.1M | $53.1M | ||
| Q2 24 | $27.0M | $53.1M | ||
| Q1 24 | $25.9M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | $-21.7M | $12.8M | ||
| Q2 25 | $-20.6M | $2.5M | ||
| Q1 25 | $-22.0M | $21.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $-25.6M | $2.8M | ||
| Q2 24 | $-23.9M | $18.5M | ||
| Q1 24 | $-23.8M | $18.8M |
| Q4 25 | 60.2% | 73.1% | ||
| Q3 25 | 42.1% | 70.6% | ||
| Q2 25 | 45.2% | 69.2% | ||
| Q1 25 | 41.3% | 79.7% | ||
| Q4 24 | 43.8% | 76.3% | ||
| Q3 24 | 38.3% | 81.5% | ||
| Q2 24 | 33.7% | 74.2% | ||
| Q1 24 | 28.6% | 72.1% |
| Q4 25 | 1.5% | 32.5% | ||
| Q3 25 | -61.4% | 36.6% | ||
| Q2 25 | -76.5% | 33.6% | ||
| Q1 25 | -73.0% | 51.1% | ||
| Q4 24 | -85.1% | 10.6% | ||
| Q3 24 | -98.0% | 26.1% | ||
| Q2 24 | -93.6% | 51.4% | ||
| Q1 24 | -99.5% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | -55.0% | 29.6% | ||
| Q2 25 | -58.8% | 5.7% | ||
| Q1 25 | -67.5% | 45.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | -91.1% | 5.3% | ||
| Q2 24 | -88.4% | 34.8% | ||
| Q1 24 | -91.9% | 34.2% |
| Q4 25 | $0.10 | $0.15 | ||
| Q3 25 | $-0.37 | $0.12 | ||
| Q2 25 | $-0.38 | $0.02 | ||
| Q1 25 | $-0.42 | $0.21 | ||
| Q4 24 | $-0.46 | $0.05 | ||
| Q3 24 | $-0.54 | $0.03 | ||
| Q2 24 | $-0.53 | $0.20 | ||
| Q1 24 | $-0.55 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $208.6M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $261.7M | $248.3M |
| Total Assets | $349.5M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $208.6M | $164.1M | ||
| Q3 25 | $244.5M | $127.4M | ||
| Q2 25 | $226.5M | $152.7M | ||
| Q1 25 | $168.2M | $132.1M | ||
| Q4 24 | $172.0M | $125.0M | ||
| Q3 24 | $151.4M | $137.4M | ||
| Q2 24 | $184.2M | — | ||
| Q1 24 | $187.8M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $261.7M | $248.3M | ||
| Q3 25 | $247.4M | $248.0M | ||
| Q2 25 | $221.0M | $244.6M | ||
| Q1 25 | $167.9M | $226.4M | ||
| Q4 24 | $180.9M | $195.1M | ||
| Q3 24 | $171.7M | $205.0M | ||
| Q2 24 | $170.6M | $8.8M | ||
| Q1 24 | $167.2M | $9.0M |
| Q4 25 | $349.5M | $380.4M | ||
| Q3 25 | $353.8M | $321.4M | ||
| Q2 25 | $321.8M | $315.3M | ||
| Q1 25 | $268.6M | $284.6M | ||
| Q4 24 | $276.1M | $266.1M | ||
| Q3 24 | $255.2M | $296.5M | ||
| Q2 24 | $309.9M | $19.5M | ||
| Q1 24 | $317.7M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.4M | $52.0M |
| Free Cash FlowOCF − Capex | $-37.2M | $51.2M |
| FCF MarginFCF / Revenue | -59.8% | 129.3% |
| Capex IntensityCapex / Revenue | 35.0% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-64.8M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.4M | $52.0M | ||
| Q3 25 | $-18.3M | $-20.9M | ||
| Q2 25 | $-1.3M | $-8.3M | ||
| Q1 25 | $-4.9M | $1.9M | ||
| Q4 24 | $-2.6M | $-7.3M | ||
| Q3 24 | $-3.8M | $5.0M | ||
| Q2 24 | $-21.6M | $19.2M | ||
| Q1 24 | $-5.7M | $3.7M |
| Q4 25 | $-37.2M | $51.2M | ||
| Q3 25 | $-20.0M | $-20.9M | ||
| Q2 25 | $-2.2M | $-8.6M | ||
| Q1 25 | $-5.4M | $1.7M | ||
| Q4 24 | $-4.0M | $-7.9M | ||
| Q3 24 | $-4.3M | $4.6M | ||
| Q2 24 | $-22.0M | $18.3M | ||
| Q1 24 | $-7.1M | $3.0M |
| Q4 25 | -59.8% | 129.3% | ||
| Q3 25 | -50.7% | -48.3% | ||
| Q2 25 | -6.3% | -19.9% | ||
| Q1 25 | -16.6% | 3.5% | ||
| Q4 24 | -13.3% | -17.8% | ||
| Q3 24 | -15.4% | 8.7% | ||
| Q2 24 | -81.5% | 34.5% | ||
| Q1 24 | -27.4% | 5.4% |
| Q4 25 | 35.0% | 2.0% | ||
| Q3 25 | 4.3% | 0.1% | ||
| Q2 25 | 2.5% | 0.7% | ||
| Q1 25 | 1.7% | 0.5% | ||
| Q4 24 | 4.8% | 1.3% | ||
| Q3 24 | 2.0% | 0.8% | ||
| Q2 24 | 1.3% | 1.6% | ||
| Q1 24 | 5.3% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OUST
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
